Re: Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine.
Lien
Ernst A
EA
Ueland
Per M
PM
Lønning
Per E
PE
D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000494:pharmacology; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000097:blood*; D020847:Estrogen Receptor Modulators / Q000008:administration & dosage / Q000097:blood*; D005260:Female; D006801:Humans; D017374:Paroxetine / Q000008:administration & dosage* / Q000494:pharmacology*; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage* / Q000494:pharmacology*; D013629:Tamoxifen / Q000008:administration & dosage / Q000097:blood*
D018687:Antidepressive Agents, Second-Generation; D018931:Antineoplastic Agents, Hormonal; D020847:Estrogen Receptor Modulators; D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors; D013629:Tamoxifen